CARDIOWAVE
CardioWave uses proprietary software algorithms and sensor technologies to read sophisticated biometrical parameters of human body. Those advanced parameters they interpret in a proper manner to show your energy, vitality and stress levels, optimal pulse level during your exercises (target training zone), and others. Sensor, algorithms, wireless technology and smartphones are giving consumers the ability to take control over their own health.
CARDIOWAVE
Industry:
Big Data Health Care Software Wearables
Founded:
2012-02-01
Address:
Palo Alto, California, United States
Country:
United States
Status:
Active
Email Addresses:
[email protected]
Total Funding:
0
Similar Organizations
InfoTmT
InfoTmT renders software-based engineering services using disruptive technologies to healthcare, recruitment & technology industries.
Intersystems
InterSystems is a vendor of software and technology for high-performance database management, integration, and health information systems.
UniExo
UniExo device reduces recovery period from injuries by assisting and supporting patients outside the healthcare facilities using exoskeleton
Founder
Investors List
MassChallenge
MassChallenge investment in Grant - CardioWave
More informations about "CardioWave"
Cardiawaves - Embedded France
With a quality management system, EN ISO 13485:2016 certified since 2019, Cardiawave has developed a non-invasive ultrasound therapy (NIUT) medical device for the treatment of Calcific Aortic Stenosis (CAS), an investigational …See details»
Company Profile: Cardiawave - Focused Ultrasound …
Oct 24, 2019 With the encouraging completion of a first-in-human feasibility study, French manufacturer Cardiawave presented results from the first 10 patients at large cardiovascular meetings. This innovative start-up’s current …See details»
Cardiawave - LinkedIn
Cardiawave | 6,968 followers on LinkedIn. Cardiawave is developing an innovative and non-invasive ultrasound treatment of aortic stenosis. | Innovation prize winner of many contests, Cardiawave is ...See details»
Cardiawave - Crunchbase Company Profile & Funding
Cardiawave is a medical device company .Cardiawave was created at the end of 2014 as a result of a partnership of over 6 years between the team at the Langevin Institute, a world leader in …See details»
Cardiawave Announces the Success of Its Clinical Trial …
Mar 14, 2022 Cardiawave announces the success of its clinical trial to treat aortic stenosis with VALVOSOFT® its disruptive, non-invasive, ultrasound treatment.See details»
The Team – Cardiawave
Won-Keun KIM MD, INTER. CARDIOLOGIST & DEP DIRECTOR AT UKGMSee details»
Cardiawave lays next steps for ultrasound therapy after …
Nov 15, 2023 Cardiawave has initiated a pivotal trial investigating its non-invasive ultrasound therapy, after its device demonstrated positive results in the treatment of calcific aortic stenosis in a first-in-human trial (FIH). The results, …See details»
Cardiawave’s non-invasive ultrasound therapy …
Nov 28, 2023 Non-invasive ultrasound therapy (NIUT) could be a safe, feasible treatment option for patients with severe symptomatic aortic stenosis who are ineligible for surgical or transcatheter valve replacement, according to early …See details»
CardioWave - Crunchbase Company Profile & Funding
CardioWave uses proprietary software algorithms and sensor technologies to read sophisticated biometrical parameters of human body.See details»
Cardiawave has positive data for cardiac ultrasound tech
Oct 29, 2024 Cardiawave said its device for the treatment of severe symptomatic calcific aortic stenosis (CAS) met the primary endpoint in a study.See details»
Our device: Valvosoft ® – Cardiawave
The disruptive and patented technology developed by Cardiawave is unique and will offer several advantages over state-of-the-art. It will allow physicians to deliver with a non-invasive …See details»
CARDIAWAVE HAS BEEN GRANTED AUTHORIZATION BY THE ANSM
Paris, November 17th, 2020 The French MedTech Cardiawave has been granted authorization by the Agence Nationale de Sécurité du Médicament et des produits de santé – ANSM (French …See details»
Cardiawave’s First-In-Human Trial Using Noninvasive Focused …
Mar 11, 2021 Key Points A Research Letter in Circulation details feasibility results from the first 10 patients treated in a clinical trial to soften calcified aortic heart valves. Six participants …See details»
Cardiawave’s Valvosoft Ultrasound Treatment for Aortic Stenosis ...
March 14, 2022—Cardiawave SA, a Paris, France-based medical device company, announced findings from its first-in-human (FIH) I safety and feasibility clinical trial of Valvosoft. Valvosoft …See details»
cardiowave.net - Главная
Cardiowave: всё закрючковано M.Minotavrovna: будут любимые группы В.Несси вместо этого) Роня: здорово:) Роня: и побольше, побольше! M.Minotavrovna: блонд редхеад как и …See details»
Current Treatment – Cardiawave
OPEN HEART SURGERY (SAVR) The standard treatment consists in replacing the aortic valve with a biological or mechanical prosthesis during open-heart surgery, performed under …See details»
News – Cardiawave
Jul 24, 2025 3-5 rue Jules Guesde, Bat B, 92300 Levallois-Perret, France + 33 (0) 1 55 26 82 16 [email protected]See details»
Cardiawave – Cardiawave
With a quality management system, EN ISO 13485:2016 certified since 2019, Cardiawave has developed a non-invasive ultrasound therapy (NIUT) medical device for the treatment of …See details»
Scientific Publications – Cardiawave
Documents, posters, manuscripts, abstracts or the like, of a scientific or medical nature, which include data, results of any clinical study or any other information.See details»
Speckle-Tracking Strain Echocardiography for the Assessment of …
14 hours ago Assessing left ventricular (LV) systolic function is essential for diagnosing and managing cardiac diseases. The complex 3-dimensional organization of the myocardial fibers …See details»